Scholars Central

Conference abstractPublished 8 Oct 2015

Design and synthesis of gyrase and topoisomerase IV inhibitors

Authors: Janarthanan Thathan, Mohammed Afzal Azam

J S S University, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bacterial resistance to antibiotics has long been recognized, and it is today considered to be a serious worldwide health problem. As a result of resistance, some bacterial infections are either difficult to treat with antibiotics or even untreatable. This problem has become especially serious with the recent development of multiple drug resistance in certain strains of bacteria, such as Streptococcus pneumoniae (sp), mycobacterium tuberculosis, and enterococcus. As a result of the need to combat drug-resistant bacteria and the increasing failure of the available drugs, there has been a resurgent interest in discovering new antibiotics. One attractive strategy for developing new antibiotics is to inhibit DNA gyrase and topoisomerase IV, bacterial enzymes necessary for DNA replication, and therefore, necessary for bacterial cell growth and division. Type II topoisomerases catalyse the inter-conversion of DNA topoisomers by transporting one DNA segment through another bacteria encode two type II topoisomerase enzymes, DNA gyrase and DNA topoisomerase IV. DNA gyrase controls DNA supercoiling and relieves topological stress. Topoisomerase IV decatenates daughter chromosomes following replication and can also relax supercoiled DNA. Bacterial type II topoisomerases form a heterotetrameric complex composed of two subunits. DNA gyrase forms an A2B2 complex comprised of GyrA and GyrB, whereas topoisomerase IV forms a C2E2 complex comprised of ParC and ParE. As bacterial resistance to antibiotics has become an important public health problem, there is a continuing need to develop newer and more potent antibiotics. More particularly, there is a need for antibiotics that represent a new class of compounds not previously used to treat bacterial infection. Compounds that target the ATP binding sites in both the GyrB (gyrase) and parE (topoisomerase IV) subunits would be useful for treating various bacterial infections.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Pharmaceutical Care & Health Systems.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutical Care & Health Systems
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Janarthanan Thathan”
  • BylineArticles whose byline prints “Mohammed Afzal Azam”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels